Total Payments
$30,582
2024 Payments
$6,369
Companies
57
Transactions
920
Medicare Patients
6,789
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$24,376 (79.7%)
Travel$6,051 (19.8%)
Education$155.95 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $24,376 | 893 | 79.7% |
| Travel and Lodging | $6,051 | 24 | 19.8% |
| Education | $155.95 | 3 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $3,919 | 43 | $0 (2024) |
| Abbott Laboratories | $3,367 | 46 | $0 (2024) |
| Boston Scientific Corporation | $2,751 | 38 | $0 (2024) |
| CVRx, Inc. | $2,321 | 30 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,745 | 49 | $0 (2024) |
| Medtronic Vascular, Inc. | $1,659 | 17 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $1,607 | 82 | $0 (2024) |
| PFIZER INC. | $1,551 | 114 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,115 | 46 | $0 (2024) |
| Amgen Inc. | $1,089 | 44 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,369 | 110 | Medtronic, Inc. ($2,108) |
| 2023 | $5,982 | 144 | Abbott Laboratories ($1,820) |
| 2022 | $3,558 | 144 | Esperion Therapeutics, Inc. ($371.56) |
| 2021 | $1,532 | 57 | Abbott Laboratories ($220.29) |
| 2020 | $641.40 | 24 | Boston Scientific Corporation ($110.04) |
| 2019 | $5,121 | 146 | Medtronic Vascular, Inc. ($1,323) |
| 2018 | $3,328 | 156 | SANOFI-AVENTIS U.S. LLC ($829.68) |
| 2017 | $4,050 | 139 | BOSTON SCIENTIFIC CORPORATION ($919.16) |
All Payment Transactions
920 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $25.75 | General |
| Category: Cardiovascular | ||||||
| 12/11/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $32.88 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $10.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/18/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $37.19 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/07/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/07/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $3.59 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/29/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $28.17 | General |
| Category: Cardiovascular | ||||||
| 10/23/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $23.66 | General |
| Category: Medical Device | ||||||
| 10/22/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $37.61 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/14/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $34.70 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $120.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/09/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/09/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $5.83 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 09/18/2024 | Baxter Healthcare | Hillrom - Cardiac Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 09/16/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $33.46 | General |
| Category: DIABETES | ||||||
| 08/28/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/26/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $29.43 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/21/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $161.46 | General |
| Category: Heart Failure and Hypertension | ||||||
| 08/21/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $20.57 | General |
| Category: Cardiovascular | ||||||
| 08/19/2024 | Chiesi USA, Inc. | KENGREAL (Drug) | Food and Beverage | Cash or cash equivalent | $19.26 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/15/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $40.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 2,971 | 10,774 | $1.7M | $680,091 |
| 2022 | 24 | 1,761 | 3,140 | $576,042 | $242,654 |
| 2021 | 13 | 1,002 | 1,747 | $393,957 | $169,554 |
| 2020 | 15 | 1,055 | 1,742 | $391,628 | $144,758 |
Total Patients
6,789
Total Services
17,403
Medicare Billing
$1.2M
Procedure Codes
82
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 250 | 2,086 | $183,568 | $108,234 | 59.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 358 | 1,002 | $230,460 | $101,824 | 44.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 241 | 2,010 | $217,188 | $83,948 | 38.7% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 228 | 1,666 | $288,218 | $76,199 | 26.4% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 80 | 81 | $128,223 | $62,227 | 48.5% |
| 33285 | Insertion of heart rhythm monitor under skin | Office | 2023 | 14 | 14 | $122,710 | $56,802 | 46.3% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 222 | 927 | $87,138 | $36,700 | 42.1% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 196 | 1,050 | $92,400 | $35,009 | 37.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 196 | 203 | $92,365 | $33,830 | 36.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 113 | 164 | $37,720 | $16,878 | 44.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 95 | 163 | $35,208 | $15,797 | 44.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 88 | 91 | $38,241 | $12,947 | 33.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 62 | 62 | $26,970 | $9,711 | 36.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 123 | 124 | $18,104 | $6,506 | 35.9% |
| 93040 | Electrocardiogram (ecg) 1 to 3 leads with review by physician | Office | 2023 | 269 | 551 | $14,326 | $5,731 | 40.0% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 15 | 80 | $20,000 | $5,401 | 27.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 22 | $6,776 | $3,347 | 49.4% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 137 | 137 | $6,987 | $2,312 | 33.1% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 14 | 74 | $4,144 | $1,566 | 37.8% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 78 | 79 | $4,345 | $1,553 | 35.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 71 | 87 | $3,132 | $1,072 | 34.2% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 11 | 11 | $2,585 | $961.95 | 37.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 11 | 11 | $1,760 | $849.31 | 48.3% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 19 | 19 | $1,121 | $368.46 | 32.9% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 25 | 25 | $775.00 | $145.75 | 18.8% |
About Dr. Damian Rasch, D.O
Dr. Damian Rasch, D.O is a Cardiovascular Disease healthcare provider based in Encinitas, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2009. The National Provider Identifier (NPI) number assigned to this provider is 1295977122.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Damian Rasch, D.O has received a total of $30,582 in payments from pharmaceutical and medical device companies, with $6,369 received in 2024. These payments were reported across 920 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($24,376).
As a Medicare-enrolled provider, Rasch has provided services to 6,789 Medicare beneficiaries, totaling 17,403 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Encinitas, CA
- Active Since 03/24/2009
- Last Updated 08/05/2015
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1295977122
Products in Payments
- LINQ II (Device) $3,744
- WATCHMAN (Device) $2,363
- Barostim Neo System (Device) $2,321
- ELIQUIS (Drug) $1,911
- MITRACLIP (Device) $1,858
- PRALUENT (Drug) $1,297
- Reveal LINQ (Device) $1,256
- ENTRESTO (Drug) $1,182
- XARELTO (Drug) $945.97
- Repatha (Biological) $792.12
- LifeVest (Device) $729.07
- VERQUVO (Drug) $622.73
- JARDIANCE (Drug) $456.22
- FARXIGA (Drug) $451.25
- MULTAQ (Drug) $447.51
- LEQVIO (Drug) $425.19
- PRALUENT ALIROCUMAB INJECTION (Biological) $403.51
- BRILINTA (Drug) $386.27
- CardioMEMS HF System (Device) $374.00
- NEXLIZET (Drug) $346.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Encinitas
Dr. Maurice Buchbinder, M.d, M.D
Cardiovascular Disease — Payments: $316,316
Cardiovascular Disease $316,316
Dr. Katherine Ludington, M.d, M.D
Cardiovascular Disease — Payments: $102,839
Cardiovascular Disease $102,839
Dr. Ali Hamzei, M.d, M.D
Cardiovascular Disease — Payments: $42,904
Cardiovascular Disease $42,904
Batyrjan Bulibek, M.d, M.D
Cardiovascular Disease — Payments: $31,240
Cardiovascular Disease $31,240
Dr. Pingfeng Du, M.d, M.D
Cardiovascular Disease — Payments: $25,600
Cardiovascular Disease $25,600
Dr. Roy Avalos, M.d, M.D
Cardiovascular Disease — Payments: $19,862
Cardiovascular Disease $19,862